The substantial beat on both earnings per share (EPS) and sales estimates for Q1 2024 suggests that CareMax is performing significantly better than expected, which could lead to increased investor confidence and a potential rise in stock price in the short term. The positive earnings surprise, especially when compared to the consensus estimate, indicates strong operational efficiency and market demand for CareMax's offerings. This performance is likely to attract positive attention from investors and analysts, potentially leading to upward price momentum.